Opportunity for Start-Ups in Continuous Glucose Monitoring

It's the end of a dynasty in the traditional market for self blood glucose testing--the test strips and hand-held monitors that patients have been using as the mainstay of their diabetes management. The four major companies, once differentiated players in a high growth market, have cut R&D and marketing budgets in the face of increasing commoditization. But a new era in continuous glucose monitoring has begun, and that sector is poised to grow in coming years, according to "US Markets for Diabetes Management Products," a report published in May 2009 by the Medtech Insight division of Elsevier Business Intelligence.

It's the end of a dynasty in the traditional market for self blood glucose testing--the test strips and hand-held monitors that patients have been using as the mainstay of their diabetes management. The four major companies, Johnson & Johnson's LifeScan Inc., Abbott Laboratories Inc., Roche, and Bayer AG's Bayer HealthCare AG, once differentiated players in a high growth market, have cut R&D and marketing budgets in the face of increasing commoditization. One of the most telling signs of that commoditization: giant retailer WalMart ("Save Money. Live Better.") already sells its own brand of meters and test strips, ReliOn, which sells for less than half the cost of competitors, and is heading toward a "one price fits all" strategy.

But a new era in continuous glucose monitoring has begun, according to Chris O'Donnell, SVP and president of the diabetes...

More from Archive

More from Medtech Insight

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.